↑ Rising
Health
Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs
Employers are resisting the expansion of GLP-1 obesity drug coverage due to the high costs associated with these treatments.
Health Insurance
1 trends tracked about this subject — the full history, oldest to newest below.